ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of pat...
FDA Device Recall #Z-1893-2020 — Class III — April 1, 2020
Recall Summary
| Recall Number | Z-1893-2020 |
| Classification | Class III — Low risk |
| Date Initiated | April 1, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Laboratories |
| Location | Abbott Park, IL |
| Product Type | Devices |
| Quantity | 65 kits total |
Product Description
ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.
Reason for Recall
Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.
Distribution Pattern
International distributed only in Mexico, no US distribution.
Lot / Code Information
Lot Numbers 01719F000 (Exp Date 14MAY2020), 02519E000 (Exp Date 09APR2020)
Other Recalls from Abbott Laboratories
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0961-2026 | Class II | Alinity ci-series System Control Module (SCM), ... | Nov 13, 2025 |
| Z-0489-2026 | Class II | Brand Name: Alinity hq Analyzer Product Name: ... | Sep 18, 2025 |
| Z-1652-2025 | Class II | Brand Name: CELL-DYN Ruby Product Name: CELL-D... | Mar 18, 2025 |
| Z-1655-2025 | Class II | Brand Name: CELL-DYN Ruby Product Name: CELL-D... | Mar 18, 2025 |
| Z-1653-2025 | Class II | Brand Name: CELL-DYN Ruby Product Name: CELL-D... | Mar 18, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.